Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse Transcriptase
Open Access
- 1 October 2000
- journal article
- research article
- Published by Elsevier BV in Structure
- Vol. 8 (10), 1089-1094
- https://doi.org/10.1016/s0969-2126(00)00513-x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Phenylethylthiazolylthiourea (PETT) Non-nucleoside Inhibitors of HIV-1 and HIV-2 Reverse TranscriptasesOnline Journal of Public Health Informatics, 2000
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Crystal Structures of HIV-1 Reverse Transcriptase in Complex with Carboxanilide Derivatives,Biochemistry, 1998
- Continuous and Discontinuous Changes in the Unit Cell of HIV-1 Reverse Transcriptase Crystals on DehydrationActa crystallographica. Section D, Structural biology, 1998
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997
- Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside InhibitorsJournal of Medicinal Chemistry, 1996
- Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitorsNature Structural & Molecular Biology, 1995
- High resolution structures of HIV-1 RT from four RT–inhibitor complexesNature Structural & Molecular Biology, 1995
- Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitorsNature Structural & Molecular Biology, 1995
- Crystals of HIV-1 Reverse Transcriptase Diffracting to 2·2 Å ResolutionJournal of Molecular Biology, 1994